It has been widely reported that mutations in the HFE gene correlate with increased cancer risk [61], and that HH patients have a 20- to 200-fold higher probability to develop liver cancer compared to control patients, culminating in deaths in 45% of all HCC patients [59,62,63,64]. The gene discussed is HFE; the disease is hepatocellular carcinoma.